KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report second quarter 2024 financial results on Wednesday, August 7, 2024. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details

The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for international callers. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (the “Freedom System”) currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit www.korumedical.com.

Contacts

Investor Contact:
Greg Chodaczek

347-620-7010

investor@korumedical.com

Staff

Recent Posts

Astrana Health and Elation Health Form Nationwide Partnership to Expand Sustainable Support Infrastructure for Primary Care Physicians

Partnership Will First Launch Value-Based Care Solution Offering to Hawai'i Provider Community ALHAMBRA, Calif., July…

2 hours ago

Waystar to Announce Second Quarter 2024 Financial Results on August 7, 2024

LEHI, Utah and LOUISVILLE, Ky., July 17, 2024 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY),…

2 hours ago

Thumos Care Leads AI-Powered Preventive Healthcare Revolution with Launched Platform

NEW YORK, July 17, 2024 /PRNewswire/ -- Thumos Care, a pioneering healthcare technology company, today…

2 hours ago

Erik Wexler to serve as the next president and CEO for Providence

The health system's current chief operating officer brings 30 years of experience, including eight with…

2 hours ago

Medicat Integrates with CCMH to Improve College Student Mental Health

ATLANTA, July 17, 2024 /PRNewswire/ -- Medicat, the leading provider of Electronic Health Records (EHR) software…

2 hours ago